Skip to Main Content

Paper Details

Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.
Alzheimers Dement
2
2023
AC, AD, APOE, Alzheimer's Disease, Alzheimer's disease, C-Reactive protein, CRP, HLA-DRB1, HLA-DRB1 rs9271192, MCP, MCP-1, apolipoprotein E, apolipoprotein E (APOE) genotype, blood MCP-1, major histocompatibility complex, Class II, DR beta 1, monocyte chemoattractant protein-1, rs9271192
Author NameAffiliation
Kathryn L LunettaBoston University School of Public Health
Rhoda AuAlzheimer's Disease Research Center, Boston University School of Medicine
Rhoda AuBoston University School of Medicine
Rhoda AuBoston University School of Public Health
Rhoda AuBoston University School of Medicine
Rhoda AuBoston University School of Medicine
Lindsay A FarrerBoston University School of Medicine
Lindsay A FarrerAlzheimer's Disease Research Center, Boston University School of Medicine
Lindsay A FarrerBoston University School of Public Health
Lindsay A FarrerBoston University School of Public Health
Lindsay A FarrerBoston University School of Medicine
Lindsay A FarrerBoston University School of Medicine
Lindsay A FarrerBoston University School of Medicine
Xiaoling ZhangBoston University School of Medicine
Xiaoling ZhangBoston University School of Public Health
  • 1 - 15

Datasets

Release 1.2